TX-DENTALMONITORING
1.6.2021 12:17:11 CEST | Business Wire | Press release
The company that pioneered the field of virtual orthodontics and has been the market leader since 2014 is revolutionizing the industry once again with the only available AI-based virtual monitoring solution applicable to both aligner and braces treatments of all types and brands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005494/en/
In an industry where a vast majority of practices are mixed users, the DentalMonitoring’s solution now allows dental professionals — whether in private practices or DSOs — to take full control of not only their aligner and but also all their braces cases. As a result DentalMonitoring expands its addressable market by close to 75%, helping more practices scale up their business, become more efficient and deliver an outstanding patient experience.
“Our solution has made yet another major breakthrough, and we are proud to unveil a new suite of functionalities of our platform,” says Philippe Salah, CEO of DentalMonitoring. “Dental professionals can now monitor all their aligner and braces cases independent of brand with the same, highly scalable AI-driven workflow. In addition to monitoring treatment progress, they can now actively define and monitor clinical goals for each patient. This results in more active control, productivity and a new level of safety and confidence for their practice: a real mindset shift for our industry.”
Salah continues: “Doctors now have complete control over all orthodontic treatment and can automatically track inter arch parameters such as the overbite, the overjet, the transverse or class correction of patients or detect the archwire and auxiliaries passivity in addition to the intra arch parameters they were already able to track with our solution. Dental professionals can virtualize and automate all non-clinical procedures and schedule appointments only when needed. At the same time, the patients’ compliance and engagement are improved, thanks to the complete revamping of our highly rated patient app.”
As the demand for remote care technology increases within the dental industry, DentalMonitoring continues to lead the way with its virtual practice solutions designed to engage, convert and monitor patients. Powered by AI and a database of over half a billion patient photographs, the virtual practice solutions are designed to give dental professionals the flexibility and convenience they need to safely address all sorts of orthodontic patient cases and optimize chair time.
About DentalMonitoring:
DentalMonitoring’s promise is to help all dental professionals improve their practice efficiency, optimize orthodontic treatment plans and enhance the patient experience thanks to its virtual practice solutions:
- SmileMate , maximizes lead engagement and patient conversion, with the ability for dental professionals to triage and qualify patients even before they step into the practice.
- DentalMonitoring , its flagship solution, monitors all treatments remotely, from aligners and braces of all brands to retention and hygiene.
DentalMonitoring operates across the United States, Europe and Asia with five offices: in Austin, TX, London, Paris, Hong Kong and Sydney.
To learn more about DentalMonitoring, visit www.dental-monitoring.com
DentalMonitoring, Smilemate and Vision are products designed and manufactured by Dental Monitoring SAS, under the DentalMind® branding for Health Care Professional.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210601005494/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Cutting-Edge Research to Industry: Focused Energy Plans Spin-Off of Sourcelight10.6.2026 11:38:00 CEST | Press release
Following its successful USD 240 million financing round, Focused Energy is continuing to systematically advance the industrialization of laser fusion as its core business. At the same time, the company plans to consolidate its activities in the field of laser-driven radiation sources into an independent entity under the name Sourcelight. With this move, Focused Energy is laying the groundwork for the industrial transfer of selected technological building blocks emerging from its laser fusion development. The spin-off demonstrates how cutting-edge research can give rise to new industry: scientific excellence is translated into industrial applications with strong value creation and growth potential. Sourcelight is intended to bring the LDRS (Laser-Driven Radiation Sources) technology developed by Focused Energy into targeted industrial applications. The technology combines laser-driven high-energy X-rays and neutrons in a single system. This enables not only high-resolution imaging, but
Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems10.6.2026 11:30:00 CEST | Press release
Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global deployment of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) systems. The collaboration aims to accelerate the development and integration of sophisticated software solutions for use with AB-BNCT while strengthening AB-BNCT's international market access and business development. By combining Cosylab's proven expertise in mission-critical software and complex system integration with Heron's end-to-end BNCT platforms, the partnership aims to drive broader global clinical adoption of this highly targeted cancer treatment modality. "AB-BNCT is emerging as one of the most promising approaches for treating difficult-to-treat and recurrent cancers," said Mark Pleško, Chief Executive Officer of Cosylab. "This collaboration reinforces our strategic focus on advancing radiation therapy technologie
GlobalFoundries and Qualinx Demonstrate First European Sovereign Manufacturing Flow for Security‑Critical Semiconductors10.6.2026 11:25:00 CEST | Press release
First end-to-end European chip manufacturing flow proven for aerospace, defence, IoT, consumer electronics and critical infrastructure GlobalFoundries (GF) and Qualinx today announced the successful completion of the first fully European-based, end-to-end semiconductor manufacturing flow at GlobalFoundries’ Dresden fab on its FDX technology. The milestone demonstrates that security-critical chips for aerospace, defence and critical infrastructure can be designed, manufactured and delivered entirely within Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610196220/en/ In this partnership, Qualinx served as the launch customer with a sophisticated GNSS SoC design for secure Positioning, Navigation and Timing (PNT) applications. The QLX3xx design targets sovereign GNSS-based PNT solutions for aerospace, defence and critical infrastructures—such as resilient timing and synchronization networks and highly integrated, ult
LTM Introduces BlueVerse™ Currency to Enable Outcome-Based Pricing in the Agentic AI Era10.6.2026 10:30:00 CEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today introduced BlueVerse™ Currency, an AI-linked commercial model that prices enterprise work by outcomes rather than effort consumed as enterprises scale agentic AI across core processes. BlueVerse Currency brings together the full BlueVerse stack—People (expertise on demand), Accelerators (reusable assets that speed delivery), Agents (autonomous AI workforce), Platforms (orchestration layer to scale delivery), and Tokens (compute and model usage)—into a single commercial construct. It introduces outcome-linked pricing tied to measurable business results, enabling shared productivity gains so clients can capture AI-driven efficiency value. The model also supports fungible resourcing, enabling reallocation mid-contract to evolving priorities, and faster reinvestment, with savings redirected into innovation. It is underpinned by a hybrid structure with fixed and variable pricing components, supported by use-case–
Smead Capital Management Extends International Value Strategy to Global Investors Through New Fund10.6.2026 09:00:00 CEST | Press release
Firm expands access to long-standing U.S.-based international strategy, bringing disciplined, value-driven investing to a broader global audience through the Smead Global ex-US Value UCITS Fund Smead Capital Management, a Phoenix-based investment management firm and a leader in value investing, today announced the launch of the Smead Global ex-US Value UCITS Fund designed to provide global investors with access to a product modeled after the firm’s long-standing Smead International Value Strategy. The Smead Global ex-US Value UCITS Fund is domiciled in Luxembourg. Investors can access the fund through Smead Capital Management’s website and it is available to professional and qualified investors through the fund’s transfer agent. The strategy that the Smead Global ex-US Value UCITS Fund is modeled after, the Smead International Value Strategy, has been a core contributor to Smead Capital Management’s outstanding performance for over a decade. Like all Smead products, the Global ex-US Va
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
